Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04843579
Title Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients (ClaSPd)
Acronym ClaSPd
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
NewYork-Presbyterian Brooklyn Methodist Hospital Brooklyn New York 11215 United States Details
Weill Cornell Medicine - Multiple Myeloma Center New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field